FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
- Citation:
- Blood vol 116 (18) 3622-3626
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- 59
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, P50 CA140158, CA140158, CA16058, CA101140, U10 CA077658, CA089341, U10 CA031946, R21 CA129657, R01 CA089341, U10 CA033601, U24 CA114725, U10 CA101140, P30 CA016058, CA77658, CA129657, CA114725, CA31946
- Corr. Author:
- Authors:
- Susan P. Whitman Kati Maharry Michael D. Radmacher Heiko Becker Krzysztof Mrózek Dean Margeson Kelsi B. Holland Yue-Zhong Wu Sebastian Schwind Klaus H. Metzeler Jing Wen Maria R. Baer Bayard L. Powell Thomas H. Carter Jonathan E. Kolitz Meir Wetzler Joseph O. Moore Richard M. Stone Andrew J. Carroll Richard A. Larson Michael A. Caligiuri Guido Marcucci Clara D. Bloomfield
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8461, CALGB-8525, CALGB-10201, CALGB-8923, CALGB-9420, CALGB-9720
- Phases:
- 1, 3, N/A
- Keywords:
- Myeloid Neoplasia, Brief Report